Latest Content

Gut health booms in 2026, but biomarkers lag; new consensus definitions and IAFNS reviews spotlight symptom-based measures and research gaps.

At SupplySide Connect New Jersey, Jim Roza explains how domestic partnerships, seed innovation, and close-to-source manufacturing are shaping more consistent, clinically relevant botanical extracts.

New legislation introduced by Rep. Maxine Dexter aims to establish a federal product registry, drawing mixed reactions from leading industry organizations over implementation and impact.

The new program addresses key challenges in botanical testing, including inconsistent methodologies and variability in analytical results, by delivering real-world data, case studies, and expert guidance to improve accuracy and industry transparency.

Nutritional Outlook interviews Paula Simpson about trends in nutricosmetics that are driving innovation and growth in the category.

Choosing design over proximity in clinical research. Why robust design, objective endpoints and clear biology outweigh geography in FDA and EMA reviews.

At SupplySide Connect New Jersey, Suresh Lakshmikanthan, PhD, Natural Remedies’ chief business officer, describes new findings on Ashwa-30 that highlight how measurable biomarkers can help practitioners tailor protocols for stress, fatigue, and physical strain.

The newly trademarked technologies will be showcased at Vitafoods Europe 2026, highlighting the platform’s dual-action effect on nutrient delivery.

Herbalist & Alchemist introduces a blended mycelium and fruiting body lion’s mane formula, reflecting rising demand for clinically relevant, clean-label nootropics.

At SupplySide Connect New Jersey, Suresh Lakshmikanthan, PhD, Natural Remedies’ chief business officer, explains how dual-standardized Ashwa-30 leverages ATP-active compounds and withanolides to deliver energy, endurance, and metabolic benefits at just 30 mg.

Nektium will showcase energy beverage concepts, featuring Zynamite RTDs and Rhodiolife-infused coffees at the event.

At a SupplySide Connect New Jersey session, industry experts unpack the trends reshaping product development, from protein dominance and fiber innovation, to sustainability, certifications, and shifting consumer trust.

At SupplySide Connect New Jersey, Keely Johnson, Arjuna Natural’s vice president of sales and marketing, discusses new clinical findings on Shoden ashwagandha, including its impact on stress, sleep, and cognitive performance in women ages 30–59.

A randomized controlled trial shows Zensera delivers same-day cognitive benefits and supports emotional balance under stress.

Latest research on magnesium L-threonate highlights cognitive, sleep, and stress benefits as demand for clinically backed brain health ingredients grows.

At SupplySide Connect New Jersey, Alicia Kasch, RIBUS’ vice president, discusses how Nu-FILL is addressing excipient challenges, and why formulators drive innovation.

The study highlights how the ingredient from Aker BioMarine is able to bypass the blood-brain barrier to deliver omega-3 fatty acids.

A court recently granted the restraining order, while industry groups challenge multiple hemp regulations imposed by the state DSHS and HHSC last month.

At SupplySide Connect New Jersey, Karen Howard, the Organic & Natural Health Association’s CEO and executive director, discusses shifting industry strategy away from fragmented lobbying toward unified, consumer-focused education to drive meaningful regulatory and public health outcomes.

The new women’s health gummy line features shatavari, vitamin D, and targeted botanicals for PMS, menopause, and prenatal support.

At this SupplySide Connect presentation, panelists discussed how lasting supplement trends are being shaped at the intersection of consumer demand for performance and longevity, the convergence of food and supplements, and the need to balance innovation with disciplined legal and regulatory compliance.

Heart health is increasingly being viewed through the lens of metabolic health, as consumers and formulators consider the interconnectedness of metabolic conditions.

In the first step in its effort to increase claim transparency and product integrity in the natural products industry, FNF has released results from third party testing of electrolyte products.

The new ingredient Leanara is designed to support muscle mass, energy, and metabolic health during weight loss, highlighting innovation in nutraceutical solutions for GLP-1 users.

Highlighting that fermented foods and beverages are more than just flavorful and nutritious, recent research has explored their role in supporting intestinal barrier function and gut health.

Unilever’s acquisition of Grüns is anticipated to increase its growth in the beauty and wellbeing space, reflecting the interest in greens nutrition and convenient supplement formats.

In a sit down with Nutritional Outlook, Brightseed’s Lee Chae explains how the company’s branded platform leverages artificial intelligence and structured biological data to accelerate ingredient discovery, strengthen substantiation, and reduce risk across nutraceutical product development.

Regulatory approval from Brazil’s health authority opens the door for Benicaros to enter a fast-growing supplement market, reinforcing global momentum for clinically validated, sustainable gut health ingredients.

In a recent public meeting hosted by FDA called "Exploring the Scope of Dietary Supplement Ingredients," stakeholders met to unpack the current language behind dietary supplement regulation and how modern products fit into the language of the statute.

The leadership transition highlights the company’s intent to scale its operations while maintaining a commitment to customers and innovation.

In a chat with Nutritional Outlook, biomedicine professor Mathias Ziegler explores the complexities of NAD+ metabolism, highlighting emerging research on CD38, mitochondrial dynamics, and the gap between biomarker gains and real-world outcomes.